08:00 , Dec 20, 2004 |  BC Week In Review  |  Company News

Ansata, Medicis deal

MRX received exclusive worldwide rights to develop Ansata's antimicrobial peptide technology, including preclinical compounds discovered using this technology. Ansata will receive and upfront payment of about $5 million and is eligible for at least $9...
08:00 , Dec 14, 2004 |  BC Extra  |  Company News

Medicis, Ansata peptide technology deal

Ansata (La Jolla, Calif.) granted MRX exclusive worldwide rights to develop Ansata's antimicrobial peptide technology, including preclinical compounds discovered using this technology. Ansata will receive and upfront payment of about $5 million and is eligible...